3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Terminated
1
Sponsor Class
INDUSTRY
3
Study Type
Interventional
4
Observational
3
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
3
Erectile Dysfunction
1
Dermatitis, Seborrheic
1
Alopecia
1
Acne Vulgaris
1
Interventions
Surveys and Questionnaires
34
Blood Specimen Collection
24
enzalutamide
18
Radiotherapy
15
Docetaxel
15
Biopsy
14
Abiraterone Acetate
14
apalutamide
13
Leuprolide
13
Interviews as Topic
13
Observation
12
Magnetic Resonance Spectroscopy
12
Watchful Waiting
10
radium Ra 223 dichloride
9
darolutamide
9
Androgen Antagonists
9
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
8
Radiosurgery
7
Magnetic Resonance Imaging
7
Brachytherapy
7
abiraterone
6
Specimen Handling
6
Amplified Fragment Length Polymorphism Analysis
6
Triptorelin Pamoate
5
Standard of Care
5
Positron Emission Tomography Computed Tomography
5
Gonadotropin-Releasing Hormone
5
Focus Groups
5
Registries
4
Radiotherapy, Intensity-Modulated
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Prostatic Neoplasms
×
Cyproterone Acetate
×
Clear all
NCT04925180
2022-01-12
Safe-CAM
Bayer
Completed
600 enrolled
NCT00919022
2012-11-01
ANES
Bayer
Terminated
194 enrolled
NCT00908674
2010-04-13
Androcur Effects on Quality of Life
Bayer
Completed
245 enrolled